Hodgkin's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Hodgkin's Disease, including details on causes, cancer, lymphoma, stages, symptoms.

Volume 2 (2005), Issue 9 (September)

1. Season of diagnosis is a prognostic factor in Hodgkin's lymphoma: a possible role of sun-induced vitamin D.
   Br J Cancer, 93(5): 571-4. [Abstract] [Full-text]
2. Salvage therapy of progressive and recurrent Hodgkin's disease: results from a multicenter study of the pediatric DAL/GPOH-HD study group.
   J Clin Oncol, 23(25): 6181-9. [Abstract] [Full-text]
3. Intra-abdominal desmoid tumor after successful treatment for Hodgkin disease.
   Pediatr Blood Cancer, 45(5): 728-31. [Abstract] [Full-text]
4. Prognostic factors and treatment outcome in childhood Hodgkin disease.
   Pediatr Blood Cancer, 45(5): 670-5. [Abstract] [Full-text]
5. Evaluation of left ventricular function in long-term survivors of childhood Hodgkin disease.
   Pediatr Blood Cancer, 45(5): 700-5. [Abstract] [Full-text]
6. JunB induced by constitutive CD30-extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase signaling activates the CD30 promoter in anaplastic large cell lymphoma and reed-sternberg cells of Hodgkin lymphoma.
   Cancer Res, 65(17): 7628-34. [Abstract] [Full-text]
7. Induction of autotaxin by the Epstein-Barr virus promotes the growth and survival of Hodgkin lymphoma cells.
   Blood, 106(6): 2138-46. [Abstract] [Full-text]
8. Long-term outcome after radiotherapy alone for lymphocyte-predominant Hodgkin lymphoma: a retrospective multicenter study of the Australasian Radiation Oncology Lymphoma Group.
   Cancer, 104(6): 1221-9. [Abstract] [Full-text]
9. State-of-the-art therapeutics: Hodgkin's lymphoma.
   J Clin Oncol, 23(26): 6400-8. [Abstract] [Full-text]
10. Molecular pathogenesis of Hodgkin's lymphoma.
    J Clin Oncol, 23(26): 6379-86. [Abstract] [Full-text]
11. Intracranial involvement in Hodgkin's disease.
    Pediatr Hematol Oncol, 22(7): 589-96. [Abstract] [Full-text]
12. The development of quality assurance programs for radiotherapy within the German Hodgkin Study Group (GHSG). Introduction, continuing work, and results of the radiotherapy reference panel.
    Strahlenther Onkol, 181(9): 557-66. [Abstract] [Full-text]
13. Longitudinal assessment of hematopoietic abnormalities after autologous hematopoietic cell transplantation for lymphoma.
    J Clin Oncol, 23(27): 6699-711. [Abstract] [Full-text]
14. Fatigue in long-term Hodgkin's Disease survivors: a follow-up study.
    J Clin Oncol, 23(27): 6587-95. [Abstract] [Full-text]
15. Stroke as a late treatment effect of Hodgkin's Disease: a report from the Childhood Cancer Survivor Study.
    J Clin Oncol, 23(27): 6508-15. [Abstract] [Full-text]
16. Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Study Group (GHSG).
    Ann Oncol, 16(10): 1683-7. [Abstract] [Full-text]
17. Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study.
    Blood, 106(7): 2444-51. [Abstract] [Full-text]
18. Hodgkin Lymphoma in adolescents.
    Cancer Treat Rev, 31(5): 339-60. [Abstract] [Full-text]

© 2004-2008 Hodgkin's Disease Research Today. All Rights Reserved.